-
-
Anti-DLL4 Reference Antibody (Smart Targeting patent anti-DLL4),, 50 микрограмм
-
Anti-DLL4 Reference Antibody (enoticumab),, 50 микрограмм
-
Anti-DLL3 Reference Antibody (rovalpituzumab),, 50 микрограмм
-
Anti-DLL4 Reference Antibody (demcizumab),, 50 микрограмм
-
Anti-DLL3 Reference Antibody (Dragonfly patent anti-DLL3),, 50 микрограмм
-
Anti-DLK1 Reference Antibody (LIV-1205),, 50 микрограмм
-
Anti-DDR1 / CD167a Reference Antibody (Imperial College anti-DDR1),, 50 микрограмм
-
Anti-DKK1 Reference Antibody (BHQ-880),, 50 микрограмм
-
Anti-DCSTAMP Reference Antibody (U.Rochester patent anti-DC-STAMP),, 50 микрограмм
-
Anti-DC-SIGN / CD209 Reference Antibody (INSERM patent anti-DC-SIGN),, 50 микрограмм
-
Anti-DCBLD2 / ESDN Reference Antibody (FA19-1),, 50 микрограмм
стр.: